Vometa FT

Indonesia • Dexa Medica

Indication

  • Acute nausea and vomiting. Not recommended for the routine prevention of postoperative vomiting.
  • Nausea and vomiting caused by levodopa and bromocriptine. It is recommended that treatment with domperidone should not exceed a period of 12 weeks.
  • Symptomatic treatment for functional dyspepsia. Not recommended for long-term treatment.
  • Acute nausea and vomiting caused by cancer chemotherapy and radiotherapy.

Composition

Domperidone 10 mg

Package

5 blisters of 10 dispersible tablets

Dosage Forms

Dispersible Tablet

ATC Classification

A03F

Warning

Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Safe if Prescribed
This item is safe for use while operating heavy machinery.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Caution
This item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Dosage

18 Years Old and Above

Functional dyspepsia:
10-20 mg, 3 times daily and 10-20 mg before bedtime, depending on clinical response. The treatment should not exceed 12 weeks.

Nausea and vomiting (including caused by levodopa and bromocriptine):
10-20 mg, with 4-8 hours interval.

Up to 18 Years

0.2-0.4 mg/kg body weight/day with 4-8 hours interval.

Instructions

Drug should be taken 15-30 minutes before meals and before bedtime. Vometa FT in the form of fast-melting tablet, can be swallowed without water.

Associated with Cancer-related Chemotherapy and Radiotherapy

0.2-0.4 mg/kg body weight/day with 4-8 hours interval.